Paketurytė Vaida, Linkuvienė Vaida, Krainer Georg, Chen Wen-Yih, Matulis Daumantas
Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius, 10257, Lithuania.
Molecular Biophysics, Technische Universität Kaiserslautern, Kaiserslautern, Germany.
Eur Biophys J. 2019 Mar;48(2):139-152. doi: 10.1007/s00249-018-1341-z. Epub 2018 Dec 8.
In rational drug design, it is important to determine accurately and with high precision the binding constant (the affinity or the change in Gibbs energy, ∆G), the change in enthalpy (ΔH), and the entropy change upon small molecule drug binding to a disease-related target protein. These thermodynamic parameters of the protein-ligand association reaction are usually determined by isothermal titration calorimetry (ITC). Here, the repeatability, precision, and accuracy of the measurement of the affinity and the change in enthalpy upon acetazolamide (AZM) interaction with human carbonic anhydrase II (CA II) are discussed based on the measurements using several ITC instruments. The AZM-CA II reaction was performed at decreasing protein-ligand concentrations until the determination of ∆G and ΔH was not possible, indicating a lower limit for accuracy. To obtain the confidence intervals (CI) of the ∆G and ΔH of AZM binding to CA II, the binding reaction was repeated numerous times at the optimal concentration of 10 µM and 25 °C temperature. The CI (at a confidence level α = 0.95) for ΔH = - 51.2 ± 1.0 kJ/mol and ∆G = - 45.4 ± 0.5 kJ/mol was determined by averaging the results of multiple repeats.
在合理药物设计中,准确且高精度地确定结合常数(亲和力或吉布斯自由能变化量,∆G)、焓变(∆H)以及小分子药物与疾病相关靶蛋白结合时的熵变至关重要。蛋白质 - 配体缔合反应的这些热力学参数通常通过等温滴定量热法(ITC)来测定。在此,基于使用多种ITC仪器的测量结果,讨论了乙酰唑胺(AZM)与人碳酸酐酶II(CA II)相互作用时亲和力和焓变测量的重复性、精密度和准确性。在降低蛋白质 - 配体浓度的条件下进行AZM - CA II反应,直到无法测定∆G和∆H,这表明存在准确性下限。为了获得AZM与CA II结合的∆G和∆H的置信区间(CI),在10 µM的最佳浓度和25°C温度下对结合反应进行了多次重复。通过对多次重复结果求平均值,确定了CI(置信水平α = 0.95),∆H = - 51.2 ± 1.0 kJ/mol,∆G = - 45.4 ± 0.5 kJ/mol。